A Study of Zolbetuximab (IMAB362) in Adults With Gastric Cancer

Clinical trial NCT03505320 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03505320
Sponsor: Astellas Pharma Global Development, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pharmacokinetics of Zolbetuximab Gastric Cancer Gastro-esophageal Junction (GEJ) Cancer Pharmacokinetics of Oxaliplatin Pharmacokinetics of Fluorouracil Bolus (5-FU)

Start date: 2018-06-29
Primary completion: 2026-12-31
Enrollment: 143

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.